UPDATE: Morgan Keegan Raises Price Target on Sabra Health Care REIT to $16

According to Morgan Keegan, Sabra Health Care REIT (NASDAQ: SBRA) price target is raised to $16.

Morgan Keegan said that it is raising its earnings estimates and price target for Sabra Health Care REIT based on the company's much better-than-expected guidance. “We are raising our price target from $15 to $16, which equates to a 34% total return. With higher 2012 earnings outlook, we believe Sabra could raise its dividend as well.”

Sabra Health Care REIT closed yesterday at $12.88.